AbCellera Biologics Inc. Common Shares vs. Abbott Laboratories
AbCellera Biologics Inc. Common Shares and Abbott Laboratories are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABCL | ABT | |
|---|---|---|
| Market Cap | $2.85 billion | $187.95 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABCL | ABT | |
|---|---|---|
| Dividend Yield | — | 2.32% |
ABCL and ABT split the dividend factors evenly.
Risk & Sentiment
| ABCL | ABT | |
|---|---|---|
| Short Interest | 0.31% | 0.57% |
ABCL leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABCL overview, ABCL financials, ABT overview, ABT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.